Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb

October 30, 2010 By Bio-Medicine.Org

SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ — Anadys
Pharmaceuticals, Inc. (Nasdaq:
ANDS) today announced the ANA598 data to be presented at the
61st Annual Meeting of the American Association for the Study of
Liver Disease (AASLD) in Boston, MA.  ANA598, the Company’s
direct-acting antiviral (DAA) being developed for the treatment of
hepatitis C, will be discussed in two presentations at the
conference:  

  • On Sunday, October 31, 2010 at 3:00 pm Eastern Daylight Time,
    Eric Lawitz, M.D., a principal investigator of the study, will give
    an oral presentation titled, “Safety and Antiviral Activity of
    ANA598 in Combination with Pegylated Interferon alpha 2A Plus
    Ribavirin in Treatment-Naive Genotype-1 Chronic HCV Patients.”
     The slides will be available on the Company’s website at www.anadyspharma.com
    following conclusion of the presentation.  
  • On Tuesday, November 2, 2010 at 7:00 am Eastern Daylight Time,
    Anadys will present data in a poster titled, “IL28B Polymorphism
    and Kinetics of Antiviral Activity for ANA598 in Combination with
    Pegylated Interferon alpha 2A Plus Ribavirin in Treatment-Naive
    Genotype-1 Chronic HCV Patients.”  The poster will be
    available on the Company’s website at www.anadyspharma.com.
     

“We are pleased with the positive clinical profile seen to date
for ANA598, as well as its preclinical properties that support
investigation of combinations with other direct antivirals,” said
James L. Freddo, M.D., Senior Vice President, Drug Development and
Chief Medical Officer of Anadys.  “In the upcoming Phase IIb
study, we look forward to testing ANA598 for the first time in
treatment-experienced patients, as well as in a larger population
of treatment-naive patients.”

In the oral pr

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech